GROUP ONE TRADING, L.P. - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 67 filers reported holding UNITY BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2022$4,000
-84.6%
9,685
-78.8%
0.00%
Q2 2022$26,000
-55.2%
45,764
-11.8%
0.00%
Q1 2022$58,000
+9.4%
51,864
+43.6%
0.00%
Q4 2021$53,000
+657.1%
36,111
+1443.9%
0.00%
Q3 2021$7,000
-68.2%
2,339
-51.5%
0.00%
Q2 2021$22,000
-88.3%
4,822
-91.1%
0.00%
-100.0%
Q3 2020$188,000
+9300.0%
54,436
+28550.5%
0.00%
Q2 2020$2,000
-80.0%
190
-82.7%
0.00%
Q2 2019$10,000
+25.0%
1,100
+10.0%
0.00%
Q1 2019$8,0001,0000.00%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
Founders Fund V Management, LLC 491,751$275,0002.22%
GSA CAPITAL PARTNERS LLP 639,937$361,0000.05%
PURA VIDA INVESTMENTS, LLC 359,089$202,0000.01%
Caption Management, LLC 725,000$409,0000.01%
Forefront Analytics, LLC 20,377$11,0000.01%
Johnson Midwest Financial, LLC 6,100$3,0000.00%
Virtu Financial LLC 62,640$35,0000.00%
Caption Management, LLC 225,000$127,0000.00%
SeaCrest Wealth Management, LLC 25,000$14,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 191,450$108,0000.00%
View complete list of UNITY BIOTECHNOLOGY INC shareholders